A Phase I study of granulocyte-macrophage-colony stimulating factor/interleukin-3 fusion protein (PIXY321) following ifosfamide, carboplatin, and etoposide therapy for children with recurrent or refractory solid tumors.

Autor: Cairo, Mitchell S., Krailo, Mark D., Weinthal, Joel A., Secola, Rita, Bergeron, Sharon, Ven, Carmella van de, Blazar, Bruce R., Garrison, Leslie, Reaman, Gregory H.
Zdroj: Cancer (0008543X); Oct1998, Vol. 83 Issue 7, p1449-1460, 12p
Databáze: Complementary Index
Externí odkaz: